|
TAX1BP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.209040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.603600E-01 |
| Normal-vs-Stage2 |
8.834000E-01 |
| Normal-vs-Stage3 |
3.228300E-02 |
| Normal-vs-Stage4 |
2.495600E-02 |
| Stage1-vs-Stage2 |
2.963400E-01 |
| Stage1-vs-Stage3 |
9.266000E-02 |
| Stage1-vs-Stage4 |
1.352590E-01 |
| Stage2-vs-Stage3 |
4.758200E-02 |
| Stage2-vs-Stage4 |
5.939900E-02 |
| Stage3-vs-Stage4 |
8.543000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.644300E-02 |
| Normal-vs-AfricanAmerican |
4.462000E-01 |
| Normal-vs-Asian |
5.297900E-02 |
| Caucasian-vs-AfricanAmerican |
8.405000E-01 |
| Caucasian-vs-Asian |
4.467000E-01 |
| AfricanAmerican-vs-Asian |
4.872200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.794100E-02 |
| Normal-vs-Female |
2.214800E-01 |
| Male-vs-Female |
2.228400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.251200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.073370E-01 |
| Normal-vs-Age(61-80Yrs) |
6.091500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.578000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.584200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.000400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.939400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.637800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.073400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.614400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.254390E-01 |
| Classical-VS-Follicular |
6.170400E-01 |
| Classical-VS-Other |
5.385200E-01 |
| Classical-VS-Normal |
4.467400E-01 |
| Tall-VS-Follicular |
2.367000E-01 |
| Tall-VS-Other |
8.582400E-01 |
| Tall-VS-Normal |
3.460200E-02 |
| Follicular-VS-Other |
7.084800E-01 |
| Follicular-VS-Normal |
3.037000E-01 |
| Other-VS-Normal |
3.149000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.938400E-02 |
| Normal-vs-N1 |
2.332100E-02 |
| N0-vs-N1 |
2.422600E-01 |
|
|
